Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus
1997/09/01 by Marc C. Hochberg · 11,544 citations
Medicine · #Citation #Computer science #Internal medicine #Library science #Lymphoma Diagnosis and Treatment #Medical physics #Medicine #Monoclonal and Polyclonal Antibodies Research #Rheumatology #Systemic Lupus Erythematosus Research
paper · doi:10.1002/art.1780400928
published in Arthritis & Rheumatism 40(9), 1725 (Wiley)
openalex publication_date 1997/09/01 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/05
Cited by
- Expansion of circulating T cells resembling follicular helper T cells is a fixed phenotype that identifies a subset of severe systemic lupus erythematosus
- Complement Alternative Pathway׳s Activation in Patients With Lupus Nephritis
- Neutrophil Heterogeneity Identifies an Association of LAMP1 With Proliferative Lupus Nephritis
- Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus
- Immunosuppressive therapy in lupus‐ and mixed connective tissue disease–associated pulmonary arterial hypertension: A retrospective analysis of twenty‐three cases
- Network analysis of associations between serum interferon‐α activity, autoantibodies, and clinical features in systemic lupus erythematosus
- Identification of an Anti–Integrin αvβ6 Autoantibody in Patients With Ulcerative Colitis
- The use of laboratory tests in the diagnosis of SLE
- Endoplasmic reticulum stress sensor IRE1α propels neutrophil hyperactivity in lupus
- Defective B cell tolerance checkpoints in systemic lupus erythematosus
- B Cell Activation and Plasma Cell Differentiation Are Promoted by IFN-λ in Systemic Lupus Erythematosus
- A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus
- Epigenetic attenuation of interferon signaling drives aging-related improvements in systemic lupus
- Risk Factors for Symptomatic Avascular Necrosis in Childhood-onset Systemic Lupus Erythematosus
- Spironolactone inhibits production of proinflammatory cytokines, including tumour necrosis factor-α and interferon-γ, and has potential in the treatment of arthritis
- Treatment of 139 Pregnancies in Antiphospholipid-positive Women Not Fulfilling Criteria for Antiphospholipid Syndrome: A Retrospective Study
- Genetic risk factors and clinical manifestations of systemic lupus erythematosus: Large‐scale analysis of genetic predisposition and disease subtypes
- A phase II, randomized, double‐blind, placebo‐controlled, dose‐ranging study of belimumab in patients with active systemic lupus erythematosus
- Systemic lupus erythematosus and the risk of cardiovascular disease: Results from the nurses' health study
- A Randomized, Placebo‐Controlled Trial of Hydroxychloroquine in Incomplete Lupus
- Systemic lupus erythematosus in Native sub-Saharan Africans: A systematic review and meta-analysis
- Phenotypic and functional analysis of EBV-specific memory CD8 cells in SLE
- Agreement between parent- and self-report of executive functioning in childhood-onset systemic lupus erythematosus: implications for clinical practice
- Applying Genetic Risk Score to Improve Risk Assessment of New‐Onset Lupus Nephritis in Systemic Lupus Erythematosus: A Large‐Scale Prospective Cohort Study
- A Phase 3 Trial of Telitacicept for Systemic Lupus Erythematosus
- Toll-like receptor expression and functional behavior in platelets from patients with systemic lupus erythematosus
- SELECTION OF ANTI-NUCLEAR ANTIGEN (ANA) REACTIVE B CELLS IN SYSTEMIC LUPUS ERYTHEMATOSUS
- Xist ribonucleoproteins promote female sex-biased autoimmunity
- Placental malperfusion and angiogenesis‐related proteins are associated with small‐for‐gestational‐age in systemic lupus erythematosus
- Hair Fluorescence Spectroscopy as a Non-Invasive Biomarker for Diagnosis and Remission Monitoring in Systemic Lupus Erythematosus
- Machine Learning-Based Identification of Novel Exosome-Derived Metabolic Biomarkers for the Diagnosis of Systemic Lupus Erythematosus and Differentiation of Renal Involvement
- Achievement of lupus low disease activity state (LLDAS) in a New Zealand cohort: a prospective study of ethnic differences in outcomes
- Subclinical atherosclerosis is associated with future cardiovascular events in lupus patients at apparent low cardiovascular risk
- Neutrophil FcγRI expression as a determinant of oxidative responses in human blood
- The long-term outcome of 93 patients with proliferative lupus nephritis
- Lupus Low Disease Activity State Achievement Is Important for Reducing Adverse Outcomes in Pregnant Patients With Systemic Lupus Erythematosus
- Role of mitochondria in the myopathy of juvenile dermatomyositis and implications for skeletal muscle calcinosis
- Distinct patterns of comorbidity prior to diagnosis of incident systemic lupus erythematosus in the Danish population
- Native T1 and T2 mapping by CMR in lupus myocarditis: Disease recognition and response to treatment
- Evaluation of a Pediatric-Adult Dyad Care Model for Transitioning Youth With Childhood-Onset Systemic Lupus Erythematosus
- Analysis of five cases of monogenic lupus related to primary immunodeficiency diseases
- Bicaudal D2 autoantibodies are highly specific for systemic sclerosis
- Urinary Soluble CD163: a Novel Noninvasive Biomarker of Activity for Lupus Nephritis
- Compromised CD4+ CD25high regulatory T‐cell function in patients with relapsing‐remitting multiple sclerosis is correlated with a reduced frequency of FOXP3‐positive cells and reduced FOXP3 expression at the single‐cell level
- Belimumab for Systemic Lupus Erythematosus
- Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
- Immune complex clearance by monocytes and macrophages in systemic lupus erythematosus
- Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis
- Apotopes and the biliary specificity of primary biliary cirrhosis†
- Retinal vascular inflammatory and occlusive changes in infectious and non-infectious uveitis
- The influence of repeated flares in response to therapy and prognosis in lupus nephritis
- Anifrolumab Plus Standard of Care Reduces Long‐Term Cardiovascular Damage in Adults With Systemic Lupus Erythematosus: Findings From a Real‐World External Control Study
- A functional variant in FCRL3, encoding Fc receptor-like 3, is associated with rheumatoid arthritis and several autoimmunities. [europepmc]
- Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. [europepmc]
- Understanding the epidemiology and progression of systemic lupus erythematosus. [europepmc]
- MicroRNA in autoimmunity and autoimmune diseases. [europepmc]
- Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis. [europepmc]
- Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans. [europepmc]
- A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus. [europepmc]
- Novel evidence-based systemic lupus erythematosus responder index. [europepmc]
- Tocilizumab in systemic lupus erythematosus: data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation study. [europepmc]
- A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis. [europepmc]
- Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. [europepmc]
- Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus. [europepmc]
- A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus. [europepmc]
- Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. [europepmc]
- Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis. [europepmc]
- Population-based incidence and prevalence of systemic lupus erythematosus: the Michigan Lupus Epidemiology and Surveillance program. [europepmc]
- Predictors of Pregnancy Outcomes in Patients With Lupus: A Cohort Study. [europepmc]
- Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseases. [europepmc]
- Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1/2 trial. [europepmc]
- Lupus nephritis is linked to disease-activity associated expansions and immunity to a gut commensal. [europepmc]
- 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. [europepmc]
- Global epidemiology of systemic lupus erythematosus. [europepmc]
- Glutathione peroxidase 4-regulated neutrophil ferroptosis induces systemic autoimmunity. [europepmc]
- B-cell depletion with obinutuzumab for the treatment of proliferative lupus nephritis: a randomised, double-blind, placebo-controlled trial. [europepmc]
- Global epidemiology of systemic lupus erythematosus: a comprehensive systematic analysis and modelling study. [europepmc]